Lei Shi is a Senior Partner and Co-Head of Eight Roads Ventures China Healthcare. The firm's profile states he has led investments in Nanos Medical, RedPine, EurekaBio, ingeDx, Precision Robotics and SonoSemi, and that he generated returns from Cytek Biosciences (NASDAQ: CTKB) and MDDF. Listed prior employers are McKinsey & Company and Baxter International.
Education
MSc (Mathematics), Technical University of Munich
MSc (Communications Engineering), Technical University of Munich
MSc (Statistics), University of California-Berkeley
PhD (Neuroscience), University of California-Berkeley